Skip to main content
. 2013 Jul 24;2(7):e59. doi: 10.1038/psp.2013.33

Figure 2.

Figure 2

Sirolimus predicted hepatic and intestinal bioavailabilities. Hepatic (Fh, a) and intestinal (Fg, b) availabilities of sirolimus were predicted based on the well-stirred model and the Qgut model, respectively, using total CYP3A content data of von Richter et al. (2004), in which genotypes of CYP3A5*1/*3 (open circle) and *3/*3 (closed circle) were investigated.17